Yonehara, International Reviews of Immunology, vol. 18, pp. 329-345 (1999).* |
Signore et al., Diabetes/Metabolism Reviews, vol. 14, pp. 197-206 (1998).* |
Rose et al., British Journal of Rheumatology, vol. 36, pp. 158-163 (1997).* |
Defranco et al., Diabetes, vol. 50, pp. 483-488 (2001).* |
Moulian et al., Blood, vol. 89, pp. 3287-3295 (1997).* |
Eguchi, Internal Medicine, vol. 40, pp. 275-284 (2001).* |
Yonehara, Cytokine and Growth Factor Reviews, vol. 13, pp. 393-402 (2002).* |
Genestier et al. Journal of Clinical Investigation, vol. 102, pp. 322-328 (1998).* |
Kerr et al., “Apoptosis: A Basic Biological phenomenon With Wide-Ranging Implications In Tissue Kinetics”, Br. J. Cancer, 26, (1972), pp. 239-257. |
Nakayama et al., “The Selection of T Cell and Apoptoss”, Mebio, 12, (10), (1995), pp. 79-86. |
Yonehara et al., “A Cell-Killing Monoclonal Antibody (Anti-Fas) To A Cell Surface Antigen Co-Downregulated With the Receptor of Tumor Necrosis Factor”, J. Exp. Med., 169, (1989), pp. 1747-1756. |
Loetscher et al., “Molecular Cloning and Expression of the Human 55 kd Tumor Necrosis Factor Receptor”, Cell, 61, (1990), pp. 351-359. |
Tsubata et al., “B-Cell Apoptosis Induced by Antigen Receptor Crosslinking is Blocked by a T-Cell signal through CD40”, Nature, 364, (1993), pp. 645-648. |
Jenne et al., “Granzymes, a Family of Serine Proteases Released from Granules of Cytolytic T Lymphocytes upon T Cell Receptor Stimulation”, Immunological Reviews, 103, (1988), pp. 53-71. |
McCarty, “Arthritis And Allied Conditions”, A Textbook of Rheumatology, 10th Edition (1985), Lea & Febiger, pp. xvii-xxii. |
Nakajima et al., “Apoptosis And Functional Fas Antigen In Rheumatoid Arthritis Synoviocytes”, Arthritis & Rheumatism, 38, (4), (1995), pp. 485-491. |
Aono et al., “Inducing Apoptosis by Using Anti Fas Antibody Against Chronic Rheumatism Synovial Cells”, 38th Japan Rheumatic Society Summary Collection, (1994), p. 487. |
Dao et al., “Relation of bcl-2 and c-myc expression to apoptosis in a human leukemia T cell line induced by natural human tumor necrosis factor- α”, Proceedings Of The Japanese Cancer Association, Japanese Journal of Cancer Research, 53 Annual Meeting, Nagoya 1994, Hesei 6, p. 338. |
Trauth et al., “Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis”, Science, 245, (1989), pp. 301-305. |
Kalden, “Anti-TNF-α and Other Treatment Principles for RA”, 7th International Rheumatology Symposium in Kyoto, (1998), pp. 12-13. |
McGahon et al., “Chemotherapeutic Drug-Induced Apoptosis in Human Leukaemic Cells is Independent of the FAS (APO-1/CD95) Receptor/Ligand System”, British Journal of Haematology, 101, (1998), pp. 539-547. |
Mizutani et al., “Doxorubicin Sensitizes Human Bladder Carcinoma Cells to Fas-Mediated Cytotoxicity”, American Cancer Society, 79, (6), (1997), pp. 1180-1189. |
Serizawa, “Trials on the Development of Drug by an Novel Anti-Fas Monoclonal Antibody”, Saishin-igaku, 54, (4), (1999), pp. 917-924. |
“Edatrexate”, The Merck Index, 3553, 12th Edition, (1996), pp. 592-593. |
Mizutani et al., “Sensitization Of Human Bladder Cancer Cells to Fas-Mediated Cytotoxicity By Cis-Diamminedichloroplatinum”, J. of Urology, 160, (2), (1998), pp. 561-571. |
“Trimetrexate”, The Merck Index, 12th Edition, 9851, (1996), p. 1656. |
“Brodimoprim”, The Merck Index, 12th Edition, 1401, (1996), p. 226. |
Kotake et al., “Synthesis and Antitumor Activities of Novel 6-5 Fused Ring Heterocycle Antifolates: N-[4[ω(2-Amino-4-Substituted-6,7-Dihydrocyclopenta[d]pyrimidin-5-yl)alkyl]benxoyl]-L-glutamic Acids”, J. Med. Chem., 37, (11), (1994), pp. 1616-1624. |
Faessel et al., “Super in Vitro Synergy between Inhibitors of Dihydrofolate Reductase and Inhibitors of Other Folate-requiring Enzymes: The Critical Role of Polyglutamylation”, Cancer Research, 58, (14), (1998), pp. 3036-3050. |
Rosowsky et al., “Synthesis and Biological Activity of Methotrexate Analogues with Two Acid Groups and a Hydrophobic Aromatic Ring in the Side Chain”, J. Med. Chem., 34, (2), (1991), pp. 574-579. |
Hughes et al., “Anti-Pneumocystis carinii Activity of PS-15, a New Biguanide Folate Antagonist”, Antimicrobial Agents And Chemotherapy, 37, (7), (1993), pp. 1417-1419. |
Genestier et al., “Immunosuppressive Properties of Methotrexate: Apoptosis and Clonal Deletion of Activated Peripheral T Cells”, J. Clin. Invest., 102, (2), (1998), pp. 322-328. |
Nishimura-Morita et al, “Amelioration of Systemic Autoimmune Disease by the Stimulation of Apoptosis-Promoting Receptor Fas with Anti-Fas mAb”, International Immunology, 9 (12); (1997), pp. 1793-1799. |
Fujisawa, “Anti-Fas mAb Therapy in Murine Arthritis”, Molecular Medicine, 33, (11), (1996), pp. 1254-1261. |
Fujisawa et al., “Therapeutic Effect of Anti-Fas Antibody on Arthritis in HTLV-I Tax Transgenic Mice”, J. Clin. Invest., 98, (2), (1998), pp. 271-278. |
Sakai et al., “Potential Withdrawal Of Rheumatoid Synovium By The Induction Of Apoptosis Using A Novel In Vivo Model Of Rheumatoid Arthritis”, Arthritis & Rheumatism, 41, (7), (1998), pp. 1251-1257. |
Hasunuma et al., “Induction of Fas-Dependent Apoptosis in Synovial Infiltrating Cells in Rheumatoid Arthritis”, Int. Imunol., 8, (10), (1996), pp. 1595-1602. |
Sumida et al., “Rheumatoid Arthritis and Apoptosis”, Intern. Med., 37, (2), (1998), pp. 184-188. |